Visual information undergoes complex processing before it can turn into a clear picture. The optic nerve is largely responsible for this process. Unfortunately, it can atrophy due to various pathological processes. Currently, there are no treatments in medicine that would completely cure degenerative diseases of the optic nerve.
Breast cancer is the most widespread type of cancer among women. Statistics in this sphere is really frightening. For example, 8 % of women in the USA have a significant risk of developing this disease. Breast cancer can affect men as well, but it is a very rare occurrence. Nevertheless, in case of detection during the early stages, this...
Cervical cancer is the second most common cancer among women under 45 years old. The most common cause of its development is human papillomavirus (HPV), due to which the tumor can appear at any age. Modern treatment methods allow doctors to control the growth and the development of tumors even at stage 4 of the malignant process, when the tumor is no longer localized.
Melanoma is one of the most aggressive malignant formations. It takes the lives of young people: many patients are in the age category of 30-40 years. Melanoma...
Immunotherapy for melanoma is the treatment of choice for patients with metastatic tumors, resistance to chemotherapeutic agents, and disease recurrence after the successful initial treatment. Vaccination with dendritic cells reboots a person's immunity, teaching it to find and attack melanoma cells throughout the body.
According to the World Health Organization, osteochondroma is an osseous projection covered by a cartilage layer that arises on the external bone surface. Such neoplasms generally arise in the immature skeleton, i.e. in children and young adolescents. Debate still continues as to the benign or potentially malignant (pseudotumoral)...
The American Society of Clinical Oncology publishes a Clinical Cancer Advances report annually. CAR T-cell therapy was presented as one of the main achievements of the year in the report for 2018. This therapy was a breakthrough in oncology, mainly in the treatment of hematologic diseases. Today, some countries use CAR T immunotherapy not only in clinical trials, but also in practical medicine.
Cancer is one of the most common causes of human deaths, along with cardiovascular pathologies. A complete cure or effective treatment has not been developed yet. Moreover, traditional therapy may not bring results to its advanced stage, so patients simply receive symptomatic treatment. The German Clinic of Advanced Biological Medicine in Frankfurt-am-Main (Germany) focuses on complex treatments for cancer patients.